IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical (ICCM) has 3 years of Long-Term Deferred Tax data on file, last reported at $17.3 million in Q4 2022.

• Long-Term Deferred Tax for Q4 2022 came in at $17.3 million, up 21.84% year-over-year; the trailing twelve-month figure through Dec 2022 was $17.3 million (up 21.84% YoY), and the FY2022 annual result was $17.3 million, up 21.84% from the prior year.
• Long-Term Deferred Tax improved to $17.3 million in Q4 2022 per ICCM's latest filing, from $14.2 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $17.3 million in Q4 2022 and troughed at $12.0 million in Q4 2020.
• A 3-year average of $14.5 million and a median of $14.2 million in 2021 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax advanced 17.94% in 2021, then rose 21.84% in 2022.
• A 3-year view of Long-Term Deferred Tax shows it stood at $12.0 million in 2020, then gained by 17.94% to $14.2 million in 2021, then grew by 21.84% to $17.3 million in 2022.
• Business Quant data shows ICCM's Long-Term Deferred Tax at $17.3 million in Q4 2022, $14.2 million in Q4 2021, and $12.0 million in Q4 2020.